Searchable abstracts of presentations at key conferences in endocrinology

ea0028p33 | Clinical biochemistry | SFEBES2012

Using salivary cortisols to aid inferior petrosal sinus sampling

Hart Tanya , Begley Joe , Richardson Tristan

A 68 yr old male with a history of type 2 diabetes presented with myalgia and girdle weakness affecting him on a frequent but episodic basis. Investigations confirmed Cyclical Cushing's Disease. Pituitary MRI was normal. Further investigations include bilateral inferior petrosal sinus sampling (BIPSS) which can help determine the origin of ACTH-dependent Cushing’s syndrome. After CRH-stimulation, a peak central to peripheral ACTH ratio of >3 suggests a pituitary ACTH ...

ea0021p85 | Clinical practice/governance and case reports | SFEBES2009

An unusual cause of hyperparathyroidism

Hart Tanya , Begley Joe , Richardson Tristan

A 28-year-old man presented to his GP in Turkey complaining of fatigue. As part of his work up, serum PTH was assessed and was found to be markedly elevated at 29.9 pmol/l (normal range 1.6–6.8), with normal calcium, phosphate, alkaline phosphatase, renal function, 1,25- and 25-hydroxy vitamin D3 levels. A DEXA scan was normal and a Sestamibi scan did not reveal any parathyroid adenoma. Prior to any further investigations or treatment, he moved to the UK.<p class="abs...

ea0086p214 | Metabolism, Obesity and Diabetes | SFEBES2022

C-peptide assessments- are we doing it correctly?

Oo Win , George Bethany , Partridge Helen , Hart Tanya , Page Georgina , Holt Helen , Brooks Augustin , Richardson Tristan

Background: C-peptide is an amino-acid chain which is an equimolar marker of endogenous insulin. It is used to investigate the cause of non-diabetic hypoglycaemia and classification of diabetes. C-peptide can only be interpreted with a paired venous glucose <3 mmol/l for non-diabetic hypoglycaemia, and >4 mmol/l for diabetes classification.Aims and Objectives: To determine if: 1. C-peptide tests were requested for appropriate indication 2. Tests ...